Two ex-sailors plead guilty after fentanyl-laced pills bought on USS Abraham Lincoln killed crewmember
Coveragetap to expand ▾Spectrum: Mostly Center🌍US: 2
- Szramowski sold cocaine and pills labeled as “Percocet” to crewmates beginning no later than August 2022, and the pills were represented as oxycodone but were actually laced with fentanyl (per nypost.com).
- A coroner determined A.N. died from ingesting fentanyl on Jan. 3, 2023 (per nypost.com).
- The defendants are described as former USS Abraham Lincoln crewmembers and a married couple; Szramowski was 29 and Poomaihealani was 25 at the time of reporting (per nypost.com).
Two former USS Abraham Lincoln sailors, Bailey A. Szramowski and Johnnese H. Poomaihealani, pleaded guilty to conspiracy to distribute controlled substances after selling counterfeit oxycodone pills that were laced with fentanyl to shipmates, prosecutors say (per nypost.com).
According to Szramowski’s plea agreement and court records, he began selling cocaine and pills labeled as “Percocet” to crewmembers by at least August 2022 and did not disclose that the pills contained fentanyl (per nypost.com). A crewmember identified only as A.N. bought 10 pills on Dec. 30, 2022 and a coroner later found that A.N. died from ingesting fentanyl on Jan.
3, 2023 (per nypost.com). The single-source reporting emphasizes the lethal outcome and the defendants’ admissions in the plea papers; the account available names the buyers, the product label used by the sellers, and the medical cause of death documented by the coroner (per nypost.com).
Prosecutors framed the case as a drug distribution conspiracy tied to active-duty sailors aboard a forward-deployed nuclear carrier, while the reporting focuses on the immediate criminal admissions in the plea agreement rather than broader Navy policy failures or chain-of-command accountability (per nypost.com).
The guilty pleas create criminal exposure for the couple and underscore how counterfeit pills containing fentanyl can circulate inside military units; the article does not include statements from defense counsel, Navy officials, or family members of A.N., and it does not report on any Navy administrative or criminal actions beyond the plea (per nypost.com).
Because coverage is limited to the plea agreement and coroner finding, key questions remain: where the pills originated before reaching Szramowski, whether other sailors were harmed, and whether the Navy will pursue separate disciplinary or prevention measures — facts not provided in the available reporting (per nypost.com).
- - A specific USS Abraham Lincoln crewmember, identified in court records only as A.N., died after ingesting fentanyl; that death imposes a concrete human cost on shipboard personnel and their families (per nypost.com). - Active-duty sailors aboard a deployed nuclear aircraft carrier were sold counterfeit pills labeled as oxycodone but laced with fentanyl, creating an acute overdose risk among a defined population aboard the ship (per nypost.com). - The defendants, Bailey A. Szramowski and Johnnese H. Poomaihealani, now face criminal penalties after pleading guilty, which benefits prosecutors seeking accountability for distribution on a military vessel (per nypost.com). - The reporting leaves open supply-chain and command-responsibility questions that, if unresolved, continue to expose other USS Abraham Lincoln sailors to illicit drugs aboard the carrier (per nypost.com).
Whether the U.S. Attorney’s Office files sentencing motions and the date of sentencing for Bailey A. Szramowski and Johnnese H. Poomaihealani as the next formal step in the criminal case (per nypost.com). 2) Whether the Navy initiates separate administrative or criminal investigations into how counterfeit pills circulated aboard the USS Abraham Lincoln and whether any commanders or personnel face discipline (per nypost.com). 3) Whether coroner or prosecutors release additional forensic or investigative findings about the pills’ origin or whether more crewmembers are identified as victims by a specified deadline in court filings (per nypost.com).
Left- and right-leaning outlets are covering this story differently — in which facts to emphasize, which context to include, and how to frame causes and consequences.
7 specific areas where coverage diverges — see below.
- Only nypost.com is available for this packet; it frames the story around the defendants’ plea agreements, the coroner’s determination, and the shipboard setting (per nypost.com).
- No source disputes the core facts in this packet, but the origin of the counterfeit pills and whether other sailors were harmed remain unclear (per nypost.com).
- No source in this pack reports whether the Navy chain of command learned of onboard drug distribution before A.N.’s death.
- No source reports the supply chain or geographic origin of the counterfeit fentanyl‑laced pills.
- No source mentions Navy disciplinary actions or policy changes related to illicit drugs aboard carriers.
- No source provides family statements from A.N. or defense counsel comments for the defendants.
- nypost.com reports Szramowski sold 10 pills to A.N. on Dec. 30, 2022 and gives ages for the defendants (29 and 25) and the coroner’s Jan. 3, 2023 date of death (per nypost.com).
- nypost.com presents Szramowski’s sales of pills (Aug. 2022 onward) and the coroner’s finding that A.N. died from ingesting fentanyl; the article links the sale and the death via the plea agreement but does not document intermediary forensic chain-of-custody beyond the coroner’s determination (per nypost.com).
- nypost.com attributes the guilty pleas and the coroner’s cause-of-death finding to court records and the plea agreement (per nypost.com).